Phase
Condition
Non-small Cell Lung Cancer
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Histologically or cytologically confirmed diagnosis of advanced or metastatic NSCLC
- Patients who receive pembrolizumab for advanced NSCLC.
- Patients who provided written informed consent.
Exclusion
Exclusion Criteria:
1.Patients who would join any interventional clinical studies from first diagnosis to theend of the pembrolizumab treatment
Study Design
Study Description
Connect with a study center
Second Affiliated Hospital, Zhejiang University of Medicine
Hangzhou, Zhejiang 310009
ChinaActive - Recruiting
The First Affiliated Hospital of College of Medicine Zhejiang University
Hangzhou, Zhejiang 310000
ChinaActive - Recruiting
the First Hospital of Jiaxing
Jiaxing, Zhejiang 314001
ChinaActive - Recruiting
Jinhua Guangfu Hospital
Jinhua, Zhejiang 321000
ChinaActive - Recruiting
Ningbo Medical Center Lihuili Eastern Hospital
Ningbo, Zhejiang 315040
ChinaActive - Recruiting
Quzhou People's Hospital
Quzhou, Zhejiang 324000
ChinaActive - Recruiting
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang 325000
ChinaActive - Recruiting
The People's Hospital of Zhuji
Zhuji, Zhejiang 310020
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.